180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF
· Real-Time Price · USD
1.29
0.40 (44.94%)
At close: May 01, 2025, 3:59 PM
1.24
-3.88%
Pre-market: May 02, 2025, 07:05 AM EDT
44.94% (1D)
| Bid | 1.18 |
| Market Cap | 6.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.17M |
| EPS (ttm) | -15.49 |
| PE Ratio (ttm) | -0.08 |
| Forward PE | 0.02 |
| Analyst | n/a |
| Ask | 1.27 |
| Volume | 2,663,188 |
| Avg. Volume (20D) | 83,773 |
| Open | 0.92 |
| Previous Close | 0.89 |
| Day's Range | 0.91 - 1.47 |
| 52-Week Range | 0.66 - 17.75 |
| Beta | 0.29 |
About ATNF
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials t...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 27, 2017
Employees 4
Stock Exchange NASDAQ
Ticker Symbol ATNF
Website https://180lifesciences.com
4 months ago
-24.03%
180 Life Sciences Corp. shares are trading lower a...
Unlock content with
Pro Subscription
6 months ago
+9.79%
180 Life Sciences shares are trading higher after Elray Resources completed a sale of proprietary technology to the company to assist in the launch of an iGaming Blockchain casino.
